Showing results (121-130 of 144) with videos related to
Sort By:
Pageof 15
Alimentary Pharmacology & Therapeutics|August 10, 2020
Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registryMarisa Iborra, Belén Beltrán, Agnes Fernández-Clotet, et al.Gut|September 1, 2012
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300Antonio Julià, Eugeni Domènech, Elena Ricart, et al.Scientific Reports|February 3, 2018
Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain studyGemma Ibáñez-Sanz, Anna Díez-Villanueva, Laura Vilorio-Marqués, et al.Clinical and Translational Gastroenterology|September 21, 2020
Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score AnalysisFiorella Cañete, Míriam Mañosa, Isabel Pérez-Martínez, et al.Journal of Gastroenterology|October 11, 2016
Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patientsMarisa Iborra, Javier Pérez-Gisbert, Marta Maia Bosca-Watts, et al.Gastroenterology|January 6, 2015
Identification of risk loci for Crohn's disease phenotypes using a genome-wide association studyArnald Alonso, Eugeni Domènech, Antonio Julià, et al.Journal of Medical Internet Research|August 27, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCUMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
The TECCU-based telemonitoring platform for Inflammatory Bowel Disease is Cost-Effective: A Multicenter GETECCU TrialMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2022
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registryMíriam Mañosa, Agnès Fernández-Clotet, Pilar Nos, et al.Journal of Crohn'S & Colitis|December 3, 2010
Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU StudyTiago Nunes, Manuel Barreiro-de Acosta, Pilar Nos, et al.Pageof 15